| 2026-03-12 |
详情>>
股本变动：
变动后总股本13185.25万股
|
| 2026-03-12 |
详情>>
业绩披露：
2025年年报每股收益-0.23美元,归母净利润-1771.68万美元,同比去年增长31.92%
|
| 2026-01-30 |
详情>>
内部人交易：
Angelis Dimitrios等共交易11笔
|
| 2025-11-12 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-0.22美元,归母净利润-1274.46万美元,同比去年增长-155.1%
|
| 2025-10-22 |
复牌提示：
2025-10-22 10:26:58 停牌，复牌日期 2025-10-22 10:31:58
|
| 2025-08-25 |
股东大会：
将于2025-10-08召开股东大会
会议内容 ▼▲
- 1.The election of five members to our board of directors to serve until the next annual meeting of stockholders or until their respective successors have been elected and qualified (“Proposal 1”).
2.The ratification of the appointment of GBQ Partners, LLC as our independent registered public accounting firm for the fiscal year ending December 31, 2025 (“Proposal 2”).
3.An amendment to our Second Amended and Restated Certificate of Incorporation, as amended, in the form attached to the proxy statement as Annex A, to, at the discretion of our board of directors, effect a reverse stock split of our issued and outstanding shares of common stock, at any time prior to the one-year anniversary date of the approval by the stockholders of such proposal at a ratio ranging from one-for-seven (1:7) to one-for-twenty-five (1:25), with the exact ratio to be set within that range at the discretion of the board of directors without further approval or authorization of our stockholders (the “Reverse Stock Split Proposal” or “Proposal 3”).
4.For purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of shares of common stock upon exercise of: (i) series A-1 warrants of the Company having an original exercise price of $0.15 per share; (ii) series A-2 warrants of the Company having an original exercise price of $0.15 per share; (iii) the placement agent warrants of the Company having an original exercise price of $0.1875 per share, in each case as issued pursuant to that certain securities purchase agreement dated July 16, 2025 (the “Nasdaq 20% Issuance Proposal” or “Proposal 4”).
5.An amendment to the 2022 Equity Incentive Plan (as amended from time to time, the “2022 Plan”), in the form attached to the proxy statement as Annex B, for the adoption of an automatic annual increase in the shares of common stock available for issuance under the 2022 Plan (“2022 Plan Evergreen Proposal” or “Proposal 5”).
6.The proposal to adjourn the annual meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of the Reverse Stock Split Proposal and/or the Nasdaq 20% Issuance Proposal (the “Adjournment Proposal” or “Proposal 6”).
7.Conduct any other business properly brought before the meeting.
|
| 2025-08-15 |
详情>>
业绩披露：
2025年中报每股收益-0.14美元,归母净利润-696.2万美元,同比去年增长-140.29%
|
| 2025-05-16 |
详情>>
业绩披露：
2025年一季报每股收益-0.06美元,归母净利润-284.99万美元,同比去年增长-100.84%
|
| 2025-05-13 |
详情>>
业绩披露：
2024年年报每股收益-0.58美元,归母净利润-2602.3万美元,同比去年增长-377.21%
|
| 2025-05-13 |
详情>>
业绩披露：
2023年年报每股收益-0.13美元,归母净利润-545.31万美元,同比去年增长-1.37%
|
| 2024-11-12 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.11美元,归母净利润-499.59万美元,同比去年增长-265.88%
|
| 2024-10-30 |
股东大会：
将于2024-12-13召开股东大会
会议内容 ▼▲
- 1.The election of five members to our board of directors to serve until the next annual meeting of stockholders or until their respective successors have been elected and qualified;
2.The ratification of the appointment of GBQ Partners, LLC as our independent registered public accounting firm for the year ending December 31, 2024.
|
| 2024-04-19 |
详情>>
业绩披露：
2024年一季报每股收益-0.03美元,归母净利润-141.9万美元,同比去年增长-64.1%
|
| 2023-12-18 |
详情>>
业绩披露：
2024年中报每股收益0.01美元,归母净利润59.01万美元,同比去年增长-84.43%
|